The Universal Group
One group. The whole stack.
Diagnostics, AI, digital health, and pharmaceuticals — vertically integrated to modernize healthcare infrastructure where the need is greatest.
Founded in Riyadh in 2024, Universal Prognostics was born from a simple observation: diagnostic labs across fast-growing markets are fragmented, underequipped, and disconnected from the systems that should make them work.
We set out to build the infrastructure layer that makes everything else possible. Not another equipment vendor — a platform that owns the whole stack.
ORIGIN TIMELINE
2024
Founded in Riyadh
Universal Prognostics launches with the TruE² bench and the vision of one integrated platform.
2024
First lab conversions
Underperforming labs become high-performance UP Labs across fast-growing markets.
2025
X Cloud & UP AI go live
Hospital information systems, agents, and screening models running inside real operations.
2025
Universal Swiss scales
400+ formulations and test-to-treat pathways close the loop from diagnosis to treatment.
Next
Universal Hospitals
An integrated hospital network for fast-growing markets — coming soon.
THE COMPANIES
Multiple companies. One vision.
Active · core
Universal Prognostics
IVD analyzers, reagents, lab conversion, and AI-supported screening — the diagnostics core.
Explore →PHILOSOPHY
Own the stack.
We control the equipment, the reagents, the software, and the operations. Vertical integration is not a strategy — it is the strategy.
Go where others won't.
Saudi Arabia. Indonesia. India. The DRC. We build where the need is greatest.
Build the system, not the product.
Any company can sell an analyzer. We build the infrastructure that makes every analyzer, every test, and every result part of one system.